Back to Search
Start Over
Viridian Therapeutics Appoints Jennifer Tousignant as CLO
- Source :
- Plus Company Updates. February 19, 2024
- Publication Year :
- 2024
-
Abstract
- WALTHAM: Viridian Therapeutics, Inc., a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, announced the appointment of Jennifer Tousignant to the role of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.786216228